SPP1-positive myeloid cell subpopulations associated with resistance to PD-1/L1 immunotherapy in lung adenocarcinoma
Authors:
Open Access
- 13 June 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
PD-1/PD-L1 immune checkpoint inhibitors have significantly improved outcomes in Lung adenocarcinoma (LUAD), yet many patients remain unresponsive due to resistance. This study aimed to identify key cellular subpopulations associated with immunotherapy resistance in LUAD. Clinical data from 197 LUAD patients treated with PD-1/PD-L1 inhibitors were retrospectively analyzed, including 79 with response and 118 with resistance. Fresh tumor tissues from three patients per group underwent single-cell RNA sequencing (scRNA-seq), and one sample per group was analyzed using spatial transcriptomics. Immunohistochemistry (IHC) and immunofluorescence (IF) were used to validate protein expression and overlapping spatial signals. scRNA-seq revealed a distinct SPP1⁺ myeloid subpopulation enriched in resistant tumors. Pseudotime analysis suggested these cells are in a differentiation state linked to tumor progression. SCENIC analysis indicated activation of transcriptional networks potentially contributes to immune suppression. Spatial transcriptomics confirmed SPP1⁺ myeloid cells were localized near tumor nests in resistant tissues, suggesting an association with immunosuppressive microenvironment. IHC and IF further validated increased SPP1 expression and its overlapping spatial signals with macrophage markers CD68 and CD163, confirming their tumor-associated macrophage identity. This study identifies SPP1⁺ myeloid cells as a subpopulation closely associated with LUAD immunotherapy resistance. They may serve as a potential candidate biomarker for predicting PD-1/PD-L1 treatment outcomes and represent targets for further functional exploration.Keywords
Funding Information
- Youth Science Fund of Xinjiang Uygur Autonomous Region Natural Science Foundation (2024D01C339)
- Youth Project of Open Project of Key Laboratory of the Ministry of Education on "Research on High incidence Diseases in Xinjiang Region" (2024C02)
This publication has 33 references indexed in Scilit:
- Single-cell transcriptomic analyses provide insights into SPP1+ TAM-mediated immune suppression and CD8+ T cell dysfunction in lung cancerCancer Immunology, Immunotherapy, 2025
- Tumour and microenvironment crosstalk in NSCLC progression and response to therapyNature Reviews Clinical Oncology, 2025
- Single-cell and spatial transcriptomics analysis of non-small cell lung cancerNature Communications, 2024
- Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategiesClinical and Translational Medicine, 2024
- Single‐cell and spatial transcriptomics reveal POSTN+ cancer‐associated fibroblasts correlated with immune suppression and tumour progression in non‐small cell lung cancerClinical and Translational Medicine, 2023
- Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeuticsGenes & Diseases, 2023
- Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventionsSignal Transduction and Targeted Therapy, 2023
- Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancerNature Communications, 2022
- Clinical relevance of tumour-associated macrophagesNature Reviews Clinical Oncology, 2022
- Understanding the tumor microenvironment for effective immunotherapyMedicinal Research Reviews, 2020